Showing results (71-80 of 451) with videos related to
Sort By:
Pageof 46
Rheumatic Diseases Clinics of North America|July 27, 2015
The Pathogenesis of Systemic SclerosisEdward P Stern, Christopher P DentonCurrent Opinion in Rheumatology|September 20, 2023
Enrichment strategies for clinical trials targeting skin fibrosis and interstitial lung disease in systemic sclerosisAriane L Herrick, Christopher P DentonAutoimmunity Reviews|July 13, 2004
Transgenic analysis of scleroderma: understanding key pathogenic events in vivoChristopher P Denton, David J AbrahamTrends in Immunology|September 20, 2005
Targeted therapy comes of age in sclerodermaChristopher P Denton, Carol M BlackRheumatic Diseases Clinics of North America|March 11, 2008
Current approaches to the management of early active diffuse scleroderma skin diseaseSvetlana I Nihtyanova, Christopher P DentonJournal of Scleroderma and Related Disorders|April 6, 2022
Aggressive combination therapy for treatment of systemic sclerosis-associated pulmonary hypertensionJ G Coghlan, Christopher P DentonCurrent Opinion in Rheumatology|September 4, 2009
Disease-modifying treatment in systemic sclerosis: current statusNiamh P Quillinan, Christopher P DentonRheumatic Diseases Clinics of North America|July 5, 2003
Pulmonary hypertension in systemic sclerosisChristopher P Denton, Carol M BlackNature Reviews. Rheumatology|February 4, 2010
Autoantibodies as predictive tools in systemic sclerosisSvetlana I Nihtyanova, Christopher P DentonNature Reviews. Rheumatology|October 1, 2014
Interstitial lung disease in connective tissue disease--mechanisms and managementAthol U Wells, Christopher P DentonPageof 46